242 related articles for article (PubMed ID: 7760008)
1. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1.
Hurley JM; Shimonkevitz R; Hanagan A; Enney K; Boen E; Malmstrom S; Kotzin BL; Matsumura M
J Exp Med; 1995 Jun; 181(6):2229-35. PubMed ID: 7760008
[TBL] [Abstract][Full Text] [Related]
2. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1.
von Bonin A; Ehrlich S; Malcherek G; Fleischer B
Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089
[TBL] [Abstract][Full Text] [Related]
3. Identification of HLA-DR alpha chain residues critical for binding of the toxic shock syndrome toxin superantigen.
Panina-Bordignon P; Fu XT; Lanzavecchia A; Karr RW
J Exp Med; 1992 Dec; 176(6):1779-84. PubMed ID: 1460432
[TBL] [Abstract][Full Text] [Related]
4. Enterotoxin residues determining T-cell receptor V beta binding specificity.
Irwin MJ; Hudson KR; Fraser JD; Gascoigne NR
Nature; 1992 Oct; 359(6398):841-3. PubMed ID: 1436060
[TBL] [Abstract][Full Text] [Related]
5. The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.
Karp DR; Teletski CL; Scholl P; Geha R; Long EO
Nature; 1990 Aug; 346(6283):474-6. PubMed ID: 2377209
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcal enterotoxin A and toxic shock syndrome toxin compete with CD4 for human major histocompatibility complex class II binding.
Bavari S; Ulrich RG
Infect Immun; 1995 Feb; 63(2):423-9. PubMed ID: 7822006
[TBL] [Abstract][Full Text] [Related]
7. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
Karp DR; Long EO
J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
[TBL] [Abstract][Full Text] [Related]
8. Sequences in both class II major histocompatibility complex alpha and beta chains contribute to the binding of the superantigen toxic shock syndrome toxin 1.
Braunstein NS; Weber DA; Wang XC; Long EO; Karp D
J Exp Med; 1992 May; 175(5):1301-5. PubMed ID: 1569399
[TBL] [Abstract][Full Text] [Related]
9. Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules.
Scholl PR; Sekaly RP; Diez A; Glimcher LH; Geha RS
Eur J Immunol; 1990 Sep; 20(9):1911-6. PubMed ID: 2209697
[TBL] [Abstract][Full Text] [Related]
10. A 21-mer synthetic peptide of toxic shock syndrome toxin 1, TSST-1[58-78], activates T cells by binding to MHC class II and by an MHC unrestricted xenostimulatory pathway.
Haregewoin A; Edwin C; Hom RC; Finberg R
Immunol Invest; 1994 Nov; 23(6-7):413-20. PubMed ID: 7851959
[TBL] [Abstract][Full Text] [Related]
11. Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR.
Vogt AB; Stern LJ; Amshoff C; Dobberstein B; Hämmerling GJ; Kropshofer H
J Immunol; 1995 Nov; 155(10):4757-65. PubMed ID: 7594477
[TBL] [Abstract][Full Text] [Related]
12. Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins.
Karp DR; Jenkins RN; Long EO
Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9657-61. PubMed ID: 1409679
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcal exotoxins deliver activation signals to human T-cell clones via major histocompatibility complex class II molecules.
Spertini F; Spits H; Geha RS
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7533-7. PubMed ID: 1881894
[TBL] [Abstract][Full Text] [Related]
14. The staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T/B cell interaction.
Mourad W; Scholl P; Diaz A; Geha R; Chatila T
J Exp Med; 1989 Dec; 170(6):2011-22. PubMed ID: 2584933
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for differential binding of staphylococcal enterotoxin A and toxic shock syndrome toxin 1 to class II major histocompatibility molecules.
Pontzer CH; Russell JK; Johnson HM
Proc Natl Acad Sci U S A; 1991 Jan; 88(1):125-8. PubMed ID: 1986357
[TBL] [Abstract][Full Text] [Related]
16. Relative activities of distinct isotypes of murine and human major histocompatibility complex class II molecules in binding toxic shock syndrome toxin 1 and determination of CD antigens expressed on T cells generated upon stimulation by the toxin.
Uchiyama T; Saito S; Inoko H; Yan XJ; Imanishi K; Araake M; Igarashi H
Infect Immun; 1990 Dec; 58(12):3877-82. PubMed ID: 2123824
[TBL] [Abstract][Full Text] [Related]
17. Residues of the variable region of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens.
Choi YW; Herman A; DiGiusto D; Wade T; Marrack P; Kappler J
Nature; 1990 Aug; 346(6283):471-3. PubMed ID: 2377208
[TBL] [Abstract][Full Text] [Related]
18. The domain structure and functional relationships in the bacterial superantigen, SEB.
Hayball JD; O'Hehir RE; Lamb JR; Lake RA
Biol Chem Hoppe Seyler; 1995 May; 376(5):303-9. PubMed ID: 7662172
[TBL] [Abstract][Full Text] [Related]
19. A toxic shock syndrome toxin 1 mutant that defines a functional site critical for T-cell activation.
Cullen CM; Blanco LR; Bonventre PF; Choi E
Infect Immun; 1995 Jun; 63(6):2141-6. PubMed ID: 7768593
[TBL] [Abstract][Full Text] [Related]
20. Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules.
Scholl P; Diez A; Mourad W; Parsonnet J; Geha RS; Chatila T
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4210-4. PubMed ID: 2542966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
